Infections by carbapenemase-producing enterobacteriaceae in a department of urology. A new challenge

Actas Urológicas Españolas (English Edition) - Tập 42 - Trang 170-175 - 2018
J. Justo-Quintas1, J. Medina-Polo1, J. Gil-Moradillo1, F. Jaén-Herreros2, A. Lara-Isla1, Á. Tejido-Sánchez1
1Servicio de Urología, Hospital Universitario 12 de Octubre, Madrid, Spain
2Servicio de Medicina Preventiva, Hospital Universitario 12 de Octubre, Madrid, Spain

Tài liệu tham khảo

Carmeli, 2010, Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control, Clin Microbiol Infect, 16, 102, 10.1111/j.1469-0691.2009.03115.x Paño Pardo, 2014, Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis, Enferm Infecc Microbiol Clin, 32, 41, 10.1016/S0213-005X(14)70173-9 Salgado, 2015, Tratamiento de infecciones causadas por enterobacterias productoras de carbapenemasas, Rev Esp Quimioter, 28, 12 Zilberberg, 2017, Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis, BMC Infect Dis, 17, 279, 10.1186/s12879-017-2383-z Maseda, 2017, Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a surgical ICU: a retrospective study, Enferm Infecc Microbiol Clin, 35, 333, 10.1016/j.eimc.2016.02.017 Rodríguez-Baño, 2015, Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology, Enferm Infecc Microbiol Clin, 33, 337, 10.1016/j.eimc.2014.11.015 Oteo, 2014, La amenaza de las enterobacterias productoras de carbapenemasas en España: documento de posicionamiento de los grupos de estudio GEIH y GEMARA de la SEIMC, Enferm Infecc Microbiol Clin, 32, 666, 10.1016/j.eimc.2014.02.011 Martínez-Martínez, 2014, Carbapenemases in Enterobacteriaceae: types and molecular epidemiology, Enferm Infecc Microbiol Clin, 32, 4, 10.1016/S0213-005X(14)70168-5 Sánchez-Romero, 2012, Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome, Antimicrob Agents Chemother, 56, 420, 10.1128/AAC.05036-11 2013, Vital signs: carbapenem-resistant Enterobacteriaceae, MMWR Morb Mortal Wkly Rep, 62, 165 Walsh, 2005, Metallo-beta-lactamases: the quiet before the storm?, Clin Microbiol Rev, 18, 306, 10.1128/CMR.18.2.306-325.2005 Tórtola, 2005, First detection of a carbapenem-hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain, Antimicrob Agents Chemother, 49, 3492, 10.1128/AAC.49.8.3492-3494.2005 Oteo, 2013, Carbapenemase-producing enterobacteriaceae in Spain in 2012, Antimicrob Agents Chemother, 57, 6344, 10.1128/AAC.01513-13 Glasner, 2013, Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013, Euro Surveill, 18, pii:20525, 10.2807/1560-7917.ES2013.18.28.20525 Brañas, 2016, Epidemiología molecular de las infecciones/colonizaciones por enterobacterias productoras de carbapenemasas en un hospital de Madrid, Enferm Infecc Microbiol Clin